Literature DB >> 24373402

[Hsa-miR-206 inhibits the migration and invasion of breast cancer by targeting Cx43].

Yun Fu1, Bei-qi Jiang1, Yi Wu1, Zheng-dong Li1, Zhi-gang Zhuang2.   

Abstract

OBJECTIVE: To explore the effects of hsa-miR-206 on the proliferation, migration and invasion of breast cancer.
METHODS: The hsa-miR-206 mimics, inhibitors and their paired negative controls were transfected into human breast cancer cell line MDA-MB-231 by liposome. The proliferation of cell was evaluated by CCK-8 and the migration and invasion was detected by Transwell. Matrix metalloproteinase 2 (MMP-2), matrix metalloproteinase 9 (MMP-9), breast cancer metastasis-suppressor 1 (BRMS-1) and connexin 43 (Cx43) were detected by both quantitative polymerase chain reaction (qPCR) and Western blot. The expression of miR-206 was detected by qPCR. Dual luciferase assay was detected to confirm the specific binding sites of miR-206 and Cx43.
RESULTS: (1) The proliferation activity of 206m-group cell (0.74 ± 0.16) was significantly lower than that of control group (1.12 ± 0.23) (t = -3.066, P = 0.037) while that of 206i-group cell (1.43 ± 0.26) was higher than that of control group (0.98 ± 0.14) (t = 3.635, P = 0.022). (2) Transwell tests showed the migration and invasion of 206m-group cell decreased significantly (migration:0.56 ± 0.01 vs 0.63 ± 0.01, t = -23.00, P = 0.002; invasion:0.79 ± 0.01 vs 0.99 ± 0.01, t = -21.200, P = 0.002), but that of 206i-group cell increased significantly (migration:0.97 ± 0.11 vs 0.61 ± 0.09, t = 32.787, P = 0.001; invasion:1.10 ± 0.01 vs 0.93 ± 0.05, t = 5.167, P = 0.035). (3) The expressions of MMP-2,MMP-9 and Cx43 decreased and the expression of BRMS-1 increased in 206m-group cell and vice versa in 206i group. (4) The expression of miR-206 in lymph node-negative group of clinical breast cancer sample was higher than that of lymph node-positive one. And there was statistical difference (Z = -2.098, P = 0.003). And the expression of Cx43 was opposite. (5) Dual luciferase reporter assay confirmed the specific binding sites of hsa-miR-206 and Cx43.
CONCLUSION: Hsa-miR-206 has negative controls of proliferation, migration and invasion of breast cancer cell by targeting Cx43.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24373402

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  5 in total

Review 1.  Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.

Authors:  Eleni van Schooneveld; Hans Wildiers; Ignace Vergote; Peter B Vermeulen; Luc Y Dirix; Steven J Van Laere
Journal:  Breast Cancer Res       Date:  2015-02-18       Impact factor: 6.466

Review 2.  microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.

Authors:  Ranjana K Kanchan; Jawed A Siddiqui; Sidharth Mahapatra; Surinder K Batra; Mohd W Nasser
Journal:  Mol Cancer       Date:  2020-02-15       Impact factor: 27.401

3.  miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells.

Authors:  Jia Ming; Yan Zhou; Junze Du; Shenghao Fan; Beibei Pan; Yinhuan Wang; Lingjun Fan; Jun Jiang
Journal:  Biosci Rep       Date:  2015-10-08       Impact factor: 3.840

4.  Identification of miR-200a as a novel suppressor of connexin 43 in breast cancer cells.

Authors:  Jia Ming; Yan Zhou; Junze Du; Shenghao Fan; Beibei Pan; Yinhuan Wang; Lingjun Fan; Jun Jiang
Journal:  Biosci Rep       Date:  2015-08-17       Impact factor: 3.840

Review 5.  Regulation of Connexins Expression Levels by MicroRNAs, an Update.

Authors:  Juan F Calderón; Mauricio A Retamal
Journal:  Front Physiol       Date:  2016-11-25       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.